Medical Condition News

RSS

Sugar consumption linked to memory problems, brain inflammation in adolescent rats

Studying rats as model subjects, scientists found that adolescents were at an increased risk of suffering negative health effects from sugar-sweetened beverage consumption.

8 Oct 2014

'Achilles heel' in metabolic pathway could stop growth of lung cancer cells

Researchers at UT Southwestern Medical Center have found an "Achilles heel" in a metabolic pathway crucial to stopping the growth of lung cancer cells.

8 Oct 2014

UCSF researchers receive five NIH awards for high-risk scientific research projects

UC San Francisco researchers received five awards announced this week by the National Institutes of Health for high-risk, high-reward scientific research projects. Their work will focus on novel approaches for diagnosing and treating diseases ranging from autoimmune and chronic inflammatory diseases, to cancer, diabetes and neurological disorders.

8 Oct 2014

BIDMC researcher receives Director's New Innovator award to study roots of hunger, cravings

Mark Andermann, PhD, a neuroendocrinology investigator at Beth Israel Deaconess Medical Center, has been awarded a prestigious Director's New Innovator award as part of the High Risk-High Reward grant program sponsored by the National Institute of Diabetes and Digestive and Kidney Disorders and the National Institutes of Health Common Fund.

8 Oct 2014

NF-kB molecule may help malignant cells hide from the immune system

A molecule that helps cancer cells evade programmed self-destruction, an internal source of death, might also help malignant cells hide from the immune system, an external source of death.

8 Oct 2014

Two UCSD professors of psychiatry honored for schizophrenia research

Two professors of psychiatry at University of California, San Diego School of Medicine have been honored by the New York City-based Brain & Behavior Research Foundation for their work studying the genetics, dysfunction and treatment of schizophrenia, a chronic and severe brain disorder affecting roughly 1 percent of the general population or approximately 3 million people.

8 Oct 2014

Researchers develop potential fast-acting "vaccine" for myasthenia gravis

Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.

8 Oct 2014

NCI awards $1.4M grant to Advanced Cell Diagnostics to develop diagnostic test for B-cell NHLs

Advanced Cell Diagnostics, Inc. (ACD), a global technology and market leader in in situ nucleic acid detection for life science research and clinical diagnostics, has been awarded a two-year, $1.4 million grant from National Cancer Institute (NCI) under its SBIR Phase II Program.

From Advanced Cell Diagnostics 7 Oct 2014

Researchers demonstrate involvement of ClpB protein in eating disorders

Eating disorders (ED) such as anorexia nervosa, bulimia, and binge eating disorder affect approximately 5-10% of the general population, but the biological mechanisms involved are unknown. Researchers at Inserm Unit 1073, "Nutrition, inflammation and dysfunction of the gut-brain axis" (Inserm/University of Rouen) have demonstrated the involvement of a protein produced by some intestinal bacteria that may be the source of these disorders.

7 Oct 2014

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there is currently no acceptable therapy.

7 Oct 2014

Genetic differences influence asthma risk in Latinos

Native American ancestry is associated with a lower asthma risk, but African ancestry is associated with a higher risk, according to the largest-ever study of how genetic variation influences asthma risk in Latinos, in whom both African and Native American ancestry is common. The study, led by UC San Francisco researchers, was published online October 6, 2014 in the Journal of Allergy and Clinical Immunology.

7 Oct 2014

Loyola Medicine, Gilda's Club Chicago launch new transition program for cancer survivors

Loyola Medicine and Gilda's Club Chicago are launching a new program to help cancer survivors make the transition from active treatment to post-treatment care.

7 Oct 2014

Clot-buster shows promise in treating less severe forms of traumatic brain injury

The only drug currently approved for treatment of stroke's crippling effects shows promise, when administered as a nasal spray, to help heal similar damage in less severe forms of traumatic brain injury.

7 Oct 2014

Alberta study shows how smaller centers drive better outcomes for patients

A new model for stroke care is being studied in rural Alberta to reduce inequities in health across communities. This model, presented at the Canadian Stroke Congress, shows how hospitals in rural areas can mimic the type of care that's often only available in larger centres.

7 Oct 2014

IRIDEX's new proprietary disposable delivery device granted U.S. patent

IRIDEX Corporation today announced that the United States Patent and Trademark Office granted the company a patent for a new proprietary disposable delivery device.

7 Oct 2014

FDA designates NurOwn as Fast Track product for ALS treatment

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the United States Food and Drug Administration (FDA) has designated NurOwn as a Fast Track product for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease).

7 Oct 2014

Scientists identify new biomarker for diagnosing cause of thyroid cancer

The expression of the protein CLIP2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin. With this discovery, scientists from the Helmholtz Zentrum München have identified a new biomarker for the diagnosis of the cancer cause.

7 Oct 2014

USC scientists find new way to suppress obesity

Imagine being able to take a pill that lets you eat all of the ice cream, cookies, and cakes that you wanted – without gaining any weight.

7 Oct 2014

UC Irvine scientist receives New Innovator Award to create stem cell-based treatments for cancer

UC Irvine scientist Weian Zhao will receive a prestigious National Institutes of Health Director's New Innovator Award to further his efforts to create stem cell-based detection methods and treatments for cancer.

7 Oct 2014

CleveXel Pharma receives license for two new oncology patents

CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d’Acceleration du Transfert de Technologies Sud Est), to exploit two patents.

7 Oct 2014

Medical Condition News

Sugar consumption linked to memory problems, brain inflammation in adolescent rats

'Achilles heel' in metabolic pathway could stop growth of lung cancer cells

UCSF researchers receive five NIH awards for high-risk scientific research projects

BIDMC researcher receives Director's New Innovator award to study roots of hunger, cravings

NF-kB molecule may help malignant cells hide from the immune system

Two UCSD professors of psychiatry honored for schizophrenia research

Researchers develop potential fast-acting "vaccine" for myasthenia gravis

NCI awards $1.4M grant to Advanced Cell Diagnostics to develop diagnostic test for B-cell NHLs

Researchers demonstrate involvement of ClpB protein in eating disorders

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Genetic differences influence asthma risk in Latinos

Loyola Medicine, Gilda's Club Chicago launch new transition program for cancer survivors

Clot-buster shows promise in treating less severe forms of traumatic brain injury

Alberta study shows how smaller centers drive better outcomes for patients

IRIDEX's new proprietary disposable delivery device granted U.S. patent

FDA designates NurOwn as Fast Track product for ALS treatment

Scientists identify new biomarker for diagnosing cause of thyroid cancer

USC scientists find new way to suppress obesity

UC Irvine scientist receives New Innovator Award to create stem cell-based treatments for cancer

CleveXel Pharma receives license for two new oncology patents

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News